Bjöern Chapuy, MD, PhD, is Associate Professor in the Department of Hematology and Oncology at the University of Göttingen, Göttingen, Germany. Dr Chapuy completed his MD, residency and fellowship at University of Göttingen. Following this, he worked as an Instructor at the Dana-Farber Cancer Institute, Boston, MA, before returning to the University of Göttingen as an Associate Professor.
Dr Chapuy also holds memberships in the following societies: the German Society for Internal Medicine, the German Society for Hematology and Oncology, the German Association of University Professors and Lecturers, the German Lymphoma Alliance, the American Society of Hematology and the American Association for Cancer Research.
Speaking on DLBCL and aggressive lymphomas
Dr Chapuy most recently has been involved in two articles which focus on B-cell lymphomas. One article highlights examples of how high‐throughput technologies aided in a better molecular understanding of large B-cell lymphomas and provided examples of how to select rationally designed targeted treatment approaches. The other article explores the multistep process of human leukocyte antigen-I (HLA-I) loss in diffuse large B-cell lymphoma (DLBCL) development including both germline and somatic events.